Solventum operates in three segments: Medsurg, Dental Solutions, and Health Information Systems, with Medsurg representing approximately 64% of revenue. The company has divested its purification and filtration segment, enabling sharper strategic focus. The recent acquisition of Acera Surgical in December 2025 expands capabilities in engineered materials for regenerative wound care, demonstrating disciplined portfolio expansion.
Cyborg Score Rationale
Solventum benefits from strong market positioning, favorable demographics in wound care and dental solutions, and a disciplined post-spin capital allocation strategy. However, legacy integration risks and competitive intensity in healthcare medtech present headwinds. Early public trading performance shows constructive momentum at $80.46/share (as of Feb 10, 2026).
Top Insights
$8.3 billion in sales in 2024 with over 20,000 employees establish significant operational scale and market presence
Medsurg contributes ~64% of revenue (wound care/prevention), while Dental and HIS each provide ~18%, creating diversified exposure
Achieved Diamond Level Resiliency Badge from Healthcare Industry Resilience Collaborative, validating supply chain strength
Diverse product portfolio spans medical solutions, oral care, health information systems, and separation sciences
Named Competitors
Baxter International — Medical devices and healthcare solutions
ResMed — Digital health and cloud-connected devices
DENTSPLY SIRONA — Dental equipment and consumables
Align Technology — Digital orthodontics and aligners
Recent Developments
(December 2025) Solventum completed acquisition of Acera Surgical, expanding synthetic tissue matrices capabilities in acute care
(August 2025) Secondary offering of 8.8M shares, with 3M reducing stake; raised ~$648M
(February 2026) Scheduled to report Q4 and full-year 2025 earnings on February 26
Open the full interactive Solventum Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.